Global Haematology Market, By Product (Haematology Analyzers, Flow Cytometers, Coagulation Analyzers, Slide Stainers, Centrifuges, Hemoglobinometers, and Others), Reagent (Coagulation Reagents, Flow Cytometry Reagents, Immuno-Haematology Reagents, and Others), Application (Drug Testing, Auto Immune Disease, Cancer, Diabetes Mellitus, Infectious Disease, and Others), End User (Hospitals, Clinical Testing Institutes, Patient Self-testing, and Other) – Industry Trends and Forecast to 2029
Haematology Market Analysis and Size
The market for haematology is likely to be driven by the rates for automated haematology instruments and the preferences for high-sensitivity point-of-care (POC) haematology tests. Rapid technology advancements, such as applying fundamental flow cytometry techniques and expanding high throughput haematology analyzers, are also projected to significantly impact the industry's drivers.
Data Bridge Market Research analyses that the haematology market which was USD 2.13 billion in 2021, would rocket up to USD 2.96 billion by 2029, and is expected to undergo a CAGR of 4.20% during the forecast period 2022 to 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2022 to 2029
|
|
Base Year
|
2021
|
|
Historic Years
|
2020 (Customizable to 2014 - 2019)
|
|
Quantitative Units
|
Revenue in USD Billion, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Product (Haematology Analyzers, Flow Cytometers, Coagulation Analyzers, Slide Stainers, Centrifuges, Hemoglobinometers, and Others), Reagent (Coagulation Reagents, Flow Cytometery Reagents, Immuno-Haematology Reagents, and Others), Application (Drug Testing, Auto Immune Disease, Cancer, Diabetes Mellitus, Infectious Disease, and Others), End User (Hospitals, Clinical Testing Institutes, Patient Self-testing, and Other)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
|
|
Market Players Covered
|
Siemens (Germany), Abbott (U.S.), Erba Mannheim (Germany), Abaxis (U.S.), Heska Corporation (U.S.), Sysmex Corporation (Japan), Danaher (U.S.), Nihon Kohden Corporation (Japan), Siemens (Germany), Abbott (U.S.), Boule Diagnostics (Sweden), HORIBA (Japan), Bio-Rad Laboratories Inc. (U.S.), BioSystems (U.S.), Diatron (Hungary), Drew Scientific (U.S.), EKF Diagnostics (U.K.), Mindray Medical India Pvt. Ltd. (China), Ortho Clinical Diagnostics (U.S.)
|
|
Market Opportunities
|
|
Market Definition
Hematology analyzers are medical instruments that are used to classify and count the number of blood cells in a patient's blood sample. Differential white blood cell counts are also analyzed using these equipment. The features of haematology analyzers vary according to the different medical equipment, and users can specify which testing service or analysis they require depending on these features.
Haematology Market Dynamics
Drivers
- Rise in chronic diseases
The rise in blood disorders and other diseases, the quick development of haematology technology, and the appearance of high throughput haematology analyzers are all factors in the expansion of the haematology market. One of the key factors influencing the market is the rising incidence of chronic blood illnesses, which is anticipated to increase demand for haematology analyzers.
- Increasing investment for healthcare infrastructure
Another significant factor influencing the growth rate of the haematology market is the rising healthcare expenditure which helps improve its infrastructure. Also, various government organizations aim to improve the healthcare infrastructure by increasing funding, which will further influence the market dynamics.
Opportunities
- Rising research and development activities
Furthermore, growing R&D initiatives demonstrating the efficacies of haematology analyzers are anticipated to benefit market expansion. For instance, automated hematologic analyzers are frequently employed in medical laboratories, according to a paper published in February 2021 titled "Establishment of enhanced review criteria for haematology analyzers in cancer institutions." The haematology analyzers market segment for cell surface markers detection will grow as a result of the hospital environment.
Restraints/Challenges
- High cost
On the other hand, the huge expense of haematology analyzers, merchandise summons, and the sluggish enactment of unconventional haematology devices in developing nations will obstruct the market's growth rate. The dearth of skilled professionals and lack of healthcare infrastructure in developing economies will challenge the haematology market.
Product recalls slow technology adoption and regulatory and reimbursement concerns are going to restrain the market in the forecast period.
This haematology market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the haematology market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
COVID-19 Impact on Haematology Market
The market has been slightly damaged by the COVID-19 pandemic. In order to measure COVID-19, haematological criteria are being stressed more widely. Using instruments like haematological analyzers, many hospitals have tested and kept track of COVID-19 patients. Important prognostic indicators such as lymphopenia, neutrophilia, leukocytosis, and thrombocytopenia—all of which are common findings in SARS-CoV-2 virus patients—can only be provided by a clinical haematology laboratory. Furthermore, hospitalization, pneumonia, and pain were more likely among COVID-19 and sickle cell disease (SCD) patients. SCD patients needed to have their health closely monitored since they were more prone to contract new infections. This had a big effect on the market.
Recent Development
- In June 2022, Thermo Fisher Scientific Inc., expanded its extensive line of automated connective tissue disease tests by releasing the new EliA RNA Pol III and EliA Rib-P blood tests to assist in the diagnosis of Systemic Sclerosis and Systemic Lupus Erythematosus (SLE)
- In May 2020, The DxH 690T haematology analyzer was introduced by Beckman Coulter, a division of Danaher Corporation, in the United States. It enables mid-volume laboratories to optimize uptime and streamline workflow.
Global Haematology Market Scope
The haematology market is segmented on the basis of product, reagent, application and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product
- Haematology Analyzers
- Flow Cytometers
- Coagulation Analyzers
- Slide Stainers
- Centrifuges
- Hemoglobinometers
- Others
Reagent
- Coagulation Reagents
- Flow Cytometery Reagents
- Immuno-Haematology Reagents
- Others
Application
- Drug Testing
- Auto Immune Disease
- Cancer
- Diabetes Mellitus
- Infectious Disease
- Others
End User
- Hospitals
- Clinical Testing Institutes
- Patient Self-testing
- Other
Haematology Market Regional Analysis/Insights
The haematology market is analyzed and market size insights and trends are provided by country, product, reagent, application and end user as referenced above.
The countries covered in the haematology market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the haematology market due to the growing geriatric population and innovative medical technology adoption.
Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2022 to 2029 due to the rising health awareness among the people and the growing demand of advanced medical technology.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Haematology Market Share Analysis
The haematology market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to haematology market.
Some of the major players operating in the haematology market are:
- Siemens (Germany)
- Abbott (U.S.)
- Erba Mannheim (Germany)
- Abaxis (U.S.)
- Heska Corporation (U.S.)
- Sysmex Corporation (Japan)
- Danaher (U.S.)
- Nihon Kohden Corporation (Japan)
- Siemens (Germany)
- Abbott (U.S.)
- Boule Diagnostics (Sweden)
- HORIBA (Japan)
- Bio-Rad Laboratories Inc. (U.S.)
- BioSystems (U.S.)
- Diatron (Hungary)
- Drew Scientific (U.S.)
- EKF Diagnostics (U.K.)
- Mindray Medical India Pvt. Ltd. (China)
- Ortho Clinical Diagnostics (U.S.)
SKU-